A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Regular insulin, which is often used in pregnancy for the treatment of diabetes, has some drawbacks: it starts its action from 30 to 60 min after subcutaneous injection and it peaks too late (2-3 ...

Transdermal delivery of insulin is not new ... studies – delivers longer-lasting and more stable levels than subcutaneous injections, without breaking the skin layers. The prototype transdermal ...

This human insulin analogue that comes in disposable pens prefilled ... Steady state is achieved after 3–4 weekly subcutaneous injections.

Ozempic has interactions with some other drugs, such as insulin, and certain supplements. Ozempic is a solution for subcutaneous injection that’s approved by the Food and Drug Administration ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...